Aberrant expression of MUC13 has been observed in various solid tumors, including hepatocellular carcinoma 25, gastric cancer 26, pancreatic cancer 27, renal cancer 28, ovarian cancer 29, and lung cancer 30, suggesting that MUC13 may have a cancer-promoting effect. This evidence concerns the gene MUC13 and ovarian cancer.